Jane Fonda announces she has been diagnosed with non-Hodgkin's Lymphoma

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Actress Jane Fonda announced that she's been diagnosed with non-Hodgkin's Lymphoma.

  • The 84-year-old in a Friday Instagram post said she has already started chemotherapy.

  • "This is a very treatable cancer," Fonda said. "80% of people survive, so I feel very lucky."

Actress Jane Fonda announced Friday that she has been diagnosed with non-Hodgkin's Lymphoma and has begun chemotherapy treatments.

The Oscar winner announced the news in a lengthy Instagram post on Friday, saying she plans to undergo chemo for six months and said she's handling the treatments "quite well."

"This is a very treatable cancer," Fonda wrote. "80% of people survive, so I feel very lucky."

The 84-year-old also acknowledged the privilege she has, citing her health insurance and access to quality doctors and treatments.

"Almost every family in America has had to deal with cancer at one time or another and far too many don't have access to the quality health care I am receiving and this is not right," Fonda said.

The longtime political activist also vowed that the cancer would not interfere with her climate activism.

"The midterms are looming, and they are beyond consequential so you can count on me to be right there together with you as we grow our army of climate champions," she said.

Fonda's career in Hollywood has spanned decades. She rose to fame with roles in films like "Barbarella" and "A Doll's House," and has continued to act in years since, starring in "9 to 5," "Monster in Law," and "The Butler." To date, Fonda has won two Oscars, a Primetime Emmy, and seven Golden Globe awards.

More recently, Fonda has earned critical acclaim for her work on the Netflix comedy "Grace and Frankie," opposite Lily Tomlin. The final twelve episodes of the series were released on the streamer earlier this year.

Read the original article on Insider